21.17
price up icon4.23%   0.86
pre-market  Vorhandelsmarkt:  26.79   5.62   +26.55%
loading

Finanzdaten der Anaptysbio Inc-Aktie (ANAB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
20.28%
7.179
9.005 3.318 3.46 1.374
Operating Expenses
3.44%
49.38
51.14 41.05 43.60 45.77
Benefits Costs and Expenses
100.00%
-
180.78 - - -
Costs And Expenses
1.93%
49.38
50.35 41.05 43.60 45.77
Operating Income/Loss
0.16%
-42.20
-42.13 -37.73 -40.14 -44.40
Nonoperating Income/Loss
2,069%
-1.735
-0.08 0.424 0.298 0.146
Income/Loss From Continuing Operations Before Tax
104.18%
7.179
-171.78 3.318 -39.84 -44.26
Income/Loss From Continuing Operations After Tax
4.09%
-43.94
-42.21 -37.31 -39.84 -44.26
Net Income/Loss
4.09%
-43.94
-42.21 -37.31 -39.84 -44.26
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
23,610%
26.80
-0.114 26.55 26.63 27.95
Diluted Average Shares
23,610%
26.80
-0.114 26.55 26.63 27.95
Basic Earnings Per Share
3.14%
-1.64
-1.59 -1.41 -1.50 -1.58
Diluted Earnings Per Share
3.14%
-1.64
-1.59 -1.41 -1.50 -1.58
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Kapitalisierung:     |  Volumen (24h):